S100P is selectively upregulated in tumor cell lines challenged with DNA cross-linking agents

Leukemia Research

Volumn 29, Issue 10, 2005, Pages 1181-1190

  Jiang, Fen ^a   Shults, Keith ^b   Flye, Leanne ^b   Hashimoto, Yuko ^a   Van Der Meer, Riet ^a   Xie, Jingping ^a   Kravtsov, Vladimir ^a   Price, James ^a   Head, David R ^a   Briggs, Robert C ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Esoterix Center for Innovation   (United States)

Author keywords

Alkylating agents; DNA damage; Myelodysplastic syndromes (MDS); S100P

Indexed keywords

ALKYLATING AGENT; ANTIGEN; CHLORMETHINE DERIVATIVE; CISPLATIN; MELPHALAN; MESSENGER RNA; MITOMYCIN C; PROTEIN DERIVATIVE; PROTEIN S100P; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CELL CYCLE G2 PHASE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; DISEASE COURSE; DNA CROSS LINKING; DNA DAMAGE; DNA MICROARRAY; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR CELL LINE; UPREGULATION;

ALKYLATING AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL SURVIVAL; CROSS-LINKING REAGENTS; FLOW CYTOMETRY; G2 PHASE; GENE EXPRESSION PROFILING; HL-60 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; KARYOTYPING; MECHLORETHAMINE; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SUBCELLULAR FRACTIONS; UP-REGULATION;

EID: 23844510182     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.03.012     Document Type: Article

References (28)

1. P. Bernell, B. Jacobsson, A. Nordgren, and R. Hast Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology Leukemia 10 1996 662 668
2. D.R. Head Proposed changes in the definitions of acute myeloid leukemia and myelodysplastic syndrome: are they helpful? Curr Opin Oncol 14 2002 19 23
3. A. Sunters, K.A. Grimaldi, R.L. Souhami, and J.A. Hartley Gene and human tumour cell line specific differences in nitrogen mustard induced DNA alkylation and interstrand crosslinking frequencies Nucleic Acids Res 26 1998 5617 5623
4. M. Berardini, W. Mackay, and E.L. Loechler Evidence for a recombination-independent pathway for the repair of DNA interstrand cross-links based on a site-specific study with nitrogen mustard Biochemistry 36 1997 3506 3513
5. J.A. Hartley, J.W. Lown, W.B. Mattes, and K.W. Kohn DNA sequence specificity of antitumor agents. Oncogenes as possible targets for cancer therapy Acta Oncol 27 1988 503 510
6. A.D. Auerbach Fanconi anemia and leukemia: tracking the genes Leukemia 6 1992 1 4
7. M. Levitus, M.A. Rooimans, J. Steltenpool, N.R.C. Cool, A.B. Oostra, and C.G. Mathew Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes Blood 103 2004 2498 2503
8. A.R. Venkitaraman Tracing the network connecting BRCA and Fanconi anaemia proteins Nat Rev Cancer 4 2004 266 276
9. A. Rothfuss, and M. Grompe Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway Mol Cell Biol 24 2004 123 134
10. Y.M.N. Akkari, R.L. Bateman, C.A. Reifsteck, S.B. Olson, and M. Grompe DNA replication is required to elicit cellular responses to psoralen-induced DNA interstrand cross-links Mol Cell Biol 20 2000 8283 8289
11. V.D. Kravtsov, T.O. Daniel, and M.J. Koury Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis Am J Pathol 155 1999 1327 1339
12. T. Arumugam, D.M. Simeone, A.M. Schmidt, and C.D. Logsdon S100P stimulates cell proliferation and survival via RAGE J Biol Chem 279 2003 5059 5065
13. A.V. Gribenko, J.E. Hopper, and G.I. Makhatadze Molecular characterization and tissue distribution of a novel member of the S100 family of EF-hand proteins Biochemistry 40 2001 15538 15548
14. M.W. Lensch, M. Tischkowitz, T.A. Christianson, C.A. Reifsteck, S.A. Speckhart, and P.M. Jakobs Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia Blood 102 2003 7 16
15. W.J. Chazin Releasing the calcium trigger Nat Struct Biol 2 1995 707 710
16. A.V. Gribenko, M. Guzman-Casado, M.M. Lopez, and G.I. Makhatadze Conformational and thermodynamic properties of peptide binding to the human S100P protein Protein Sci 11 2002 1367 1375
17. I.D. Guerreiro Da Silva, Y.F. Hu, I.H. Russo, X. Ao, A.M. Salicioni, and X. Yang S100P calcium-binding protein overexpression is associated with immortalization of human breast epithelial cells in vitro and early stages of breast cancer development in vivo Int J Oncol 16 2000 231 240
18. A. Mackay, C. Jones, T. Dexter, R.L. Silva, K. Bulmer, and A. Jones cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells Oncogene 22 2003 2680 2688
19. L. Averboukh, P. Liang, P.W. Kantoff, and A.B. Pardee Regulation of S100P expression by androgen Prostate 29 1996 350 355
20. H. Zhi, J. Zhang, G. Hu, J. Lu, X. Wang, and C. Zhou The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma Int J Cancer 106 2003 327 333
21. N. Sato, and J. Hitomi S100P expression in human esophageal epithelial cells: human esophageal epithelial cells sequentially produce different S100 proteins in the process of differentiation Anat Rec 267 2002 60 69
22. C.D. Logsdon, D.M. Simeone, C. Binkley, T. Arumugam, J.K. Greenson, and T.J. Giordano Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2003 2649 2657
23. B. Hellung Schonning, M. Bevort, S. Mikkelsen, M. Andresen, P. Thomsen, and H. Leffers Human papillomavirus type 16 E7-regulated genes: regulation of S100P and ADP/ATP carrier protein genes identified by differential-display technology J Gen Virol 81 2000 1009 1015
24. J. Bertram, K. Palfner, W. Hiddemann, and M. Kneba Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gene expression Anticancer Drugs 9 1998 311 317
25. R. Donato Intracellular and extracellular roles of S100 proteins Microsc Res Tech 60 2003 540 551
26. M. Wasner, U. Haugwitz, W. Reinhard, K. Tschop, K. Spiesbach, and J. Lorenz Three CCAAT-boxes and a single cell cycle genes homology region (CHR) are the major regulating sites for transcription from the human cyclin B2 promoter Gene 312 2003 225 237
27. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, and P.C. Marchisio Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
28. D.C. Altieri The molecular basis and potential role of survivin in cancer diagnosis and therapy Trends Mol Med 7 2001 542 546